(Q39447513)

12 September 2017

title

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo (English)

1 reference

12 September 2017

1 reference

hepatocellular carcinoma

1 reference

1 reference

X-X He

1

1 reference

12 September 2017

Y Chang

2

1 reference

12 September 2017

F-Y Meng

3

1 reference

12 September 2017

M-Y Wang

4

1 reference

12 September 2017

Q-H Xie

5

1 reference

12 September 2017

F Tang

6

1 reference

12 September 2017

P-Y Li

7

1 reference

12 September 2017

Y-H Song

8

1 reference

12 September 2017

J-S Lin

9

1 reference

12 September 2017

language of work or name

English

0 references

publication date

7 November 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

31

1 reference

12 September 2017

issue

28

1 reference

12 September 2017

page(s)

3357-3369

1 reference

MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

The impact of microRNAs on protein output

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

MicroRNA involvement in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

The multifaceted role of MTDH/AEG-1 in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

New insights into functional aspects of liver morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Porcine hepatocyte isolation and reversible immortalization mediated by retroviral transfer and site-specific recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

MicroRNA silencing in primates: towards development of novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Lentivirus-mediated antagomir expression for specific inhibition of miRNA function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

miRNAs and their potential for use against cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.500

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.500

1 reference

12 September 2017

1 reference